BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1412138)

  • 1. Assessment of the efficacy of vasodilator drugs in peripheral vascular disease through a study of skeletal muscle metabolism using 31P nuclear magnetic resonance (NMR) spectroscopy.
    Wahl D; Simon JP; Escanye JM; Jouanny P; Robin B; Walker P; Paille F; Schmidt C; Robert J; Schmitt J
    Therapie; 1992; 47(2):125-6. PubMed ID: 1412138
    [No Abstract]   [Full Text] [Related]  

  • 2. [31P magnetic resonance spectroscopy: a noninvasive method for studying skeletal muscle metabolism in patients with arteriosclerosis obliterans of the vessels of the lower extremities and for assessing the efficacy of vasoprostan therapy].
    Sinitsyn VE; Veselova TN; Bakharev AO; Karpov IuA
    Ter Arkh; 1996; 68(12):69-72. PubMed ID: 9054047
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
    Giulini SM; Agus GB; De Cristoforo A
    Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with the new vasotherapeutic drug Trental in dermatology].
    Herger R
    Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
    [No Abstract]   [Full Text] [Related]  

  • 7. 31P in-vivo spectroscopic study by high-field whole-body MR system--an application to a case with arteriosclerosis obliterans.
    Nishimura T; Imakita S; Naito H; Takamiya M; Matsuo H; Nakayama R
    Angiology; 1987 Aug; 38(8):609-13. PubMed ID: 3631643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phosphorus-31 NMR spectrometry of the calf muscles in patients with arterial claudication. Preliminary results].
    Le Bas JF; Reutenauer H; Franco A; Magne JL; Benabid AL
    J Mal Vasc; 1987; 12(1):70-7. PubMed ID: 3559414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiischemic efficacy of trimetazidine in patients with intermittent claudication and effort angina].
    Syrkin AL; Artiukhina EG; Kanorskiĭ SG; Chuntyzheva MM
    Kardiologiia; 2003; 43(7):49-52. PubMed ID: 12891299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical stimulation of human muscle studied using 31P-nuclear magnetic resonance spectroscopy.
    Shenton DW; Heppenstall RB; Chance B; Glasgow SG; Schnall MD; Sapega AA
    J Orthop Res; 1986; 4(2):204-11. PubMed ID: 3712128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vasodilating drugs in peripheral vascular disease.
    Karpman HL; Okun R
    Geriatrics; 1972 Nov; 27(11):101-7. PubMed ID: 4562846
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphorus magnetic resonance spectroscopy: a noninvasive technique for the study of occlusive arterial leg disease and peripheral vasodilator therapy.
    Wahl DG; Simon JP; Robin B; Walker P; Jouanny P; Escanye JM; Paille F; Schmidt C; Brunotte F; Robert J
    Angiology; 1994 May; 45(5):367-76. PubMed ID: 8172384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the metabolic characteristics of slowly- and rapidly-contracting fibers in human skeletal muscle using 31P-nuclear magnetic resonance spectroscopy].
    Mitsuno M; Khorn A; Zekher N; Kvistorf B
    Fiziol Cheloveka; 1993; 19(1):34-40. PubMed ID: 8500674
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of various vasodilator agents by measuring the isotopic peripheral flow].
    Spach MO; Schwartz J
    Therapie; 1977; 32(3):301-8. PubMed ID: 337564
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
    Coscia M
    Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vasodilator drugs and obliterating arterial diseases of the lower extremities].
    Larsen OA; Lassen NA
    Ugeskr Laeger; 1967 Sep; 129(36):1168-71. PubMed ID: 5598859
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphorus nuclear magnetic resonance: a non-invasive technique for the study of muscle bioenergetics during exercise.
    Sapega AA; Sokolow DP; Graham TJ; Chance B
    Med Sci Sports Exerc; 1993 Jun; 25(6):656-66. PubMed ID: 8321101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
    Aviado DM
    Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilator drugs and peripheral vascular disease.
    Drug Ther Bull; 1972 Nov; 10(23):91-2. PubMed ID: 4144248
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phonoangiographic demonstration of the effect of various vasodilators on patients with peripheral obliterans arteriosclerosis].
    Meciani L; Tealdi D; Santa A; Ricci G
    Minerva Cardioangiol; 1969 Nov; 17(11):942-7. PubMed ID: 5404822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.